By Edwin Musoni
About 100,000 girls in primary schools will benefit from a new vaccine against Human Papilloma Virus (HPV) which causes cervical cancer.
This was revealed by the head of adolescent and reproductive health in the Ministry of Health, Dr. Diane Mutamba, in an interview with The New Times.
“The official launch of the HPV vaccine will be on April 26 and we expect to give this vaccine to over 100,000 girls across the country,” said Mutamba.
First Lady, Jeannette Kagame, will preside over the launch of the vaccine known as Gardasil, which is manufactured by Merck pharmaceutical company.
[Note from SaneVax: The headline says it all – why is the press still promoting this as a cervical cancer vaccine? Even the CDC says no one will know for decades whether this vaccine has any impact whatsoever on cervical cancer. Still, 100,000 more young girls are being targeted for inocculation and led to believe they will be protected. Someone needs to inform the First Lady of Rwanda before adverse events begin to mount up in her country also.]